Order byBest matchMost fresh
Trump administration set to limit COVID-19 shot approvals to the elderly, highest-risk
Top officials in the Trump administration on Tuesday announced they will limit the approval of new COVID-19 vaccines to adults over 65 and people who are high risk. The move is a significant shift
Forbes6m
FDA Changes May Limit COVID Vaccine Access—Drawing Some Criticism. Here’s What We Know
The Food and Drug Administration announced Tuesday it is adopting a new regulatory framework for COVID-19 vaccines that will likely narrow recommendations for the vaccines to people over 65 and those at high risk for severe outcomes—a switch that could ...
Fierce Pharma2h
FDA lays out stricter COVID vaccine policy in pivot from 'one-size-fits-all' approach
The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in certain populations. | FDA Commissioner Marty Makary, M.D and CBER head Vinay Prasad,
Researchers explore COVID-19 vaccine attitudes and motivations, finding common values
Since the COVID-19 pandemic, there has been a decline in U.S. vaccine uptake, while widespread misinformation and distrust make it challenging to craft effective public health responses.
Feedback